Droloxifene 25 mg | ≥98% LKT Laboratories, Inc. Triphenylthylene, tamoxifen analog; SERM. More Information Supplier Page × Droloxifene
Doxapram Hydrochloride Hydrate 500 mg | ≥98% LKT Laboratories, Inc. K+ channel blocker, catecholamine release stimulator. More Information Supplier Page × Doxapram Hydrochloride Hydrate
Doxapram Hydrochloride Hydrate 100 mg | ≥98% LKT Laboratories, Inc. K+ channel blocker, catecholamine release stimulator. More Information Supplier Page × Doxapram Hydrochloride Hydrate
Doxapram Hydrochloride Hydrate 25 mg | ≥98% LKT Laboratories, Inc. K+ channel blocker, catecholamine release stimulator. More Information Supplier Page × Doxapram Hydrochloride Hydrate
Doxofylline 25 g | ≥98% LKT Laboratories, Inc. Xanthine derivative; PDE inhibitor. More Information Supplier Page × Doxofylline
Meso-2,3-dimercaptosuccinic Acid 25 g | ≥98% LKT Laboratories, Inc. Organosulfur, chelating agent. More Information Supplier Page × Meso-2,3-dimercaptosuccinic Acid
Meso-2,3-dimercaptosuccinic Acid 5 g | ≥98% LKT Laboratories, Inc. Organosulfur, chelating agent. More Information Supplier Page × Meso-2,3-dimercaptosuccinic Acid
Meso-2,3-dimercaptosuccinic Acid 1 g | ≥98% LKT Laboratories, Inc. Organosulfur, chelating agent. More Information Supplier Page × Meso-2,3-dimercaptosuccinic Acid
17-Dimethylaminoethylamino Demethoxygeldanamycin 5 mg | ≥98% LKT Laboratories, Inc. Geldanamycin derivative; HSP90 inhibitor. More Information Supplier Page × 17-Dimethylaminoethylamino Demethoxygeldanamycin
17-Dimethylaminoethylamino Demethoxygeldanamycin 1 mg | ≥98% LKT Laboratories, Inc. Geldanamycin derivative; HSP90 inhibitor. More Information Supplier Page × 17-Dimethylaminoethylamino Demethoxygeldanamycin
